Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J.M. Martinez-Sesmero
Pms51 - Cost-Effectiveness of Tofacitinib-Containing Sequences for Rheumatoid Arthritis Patients in Spain
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
The Cost-Effectiveness of Alternative Treatment Sequences in Rheumatoid Arthritis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Adalimumab for Rheumatoid Arthritis in Germany
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost Effectiveness of TNF-αInhibitors in Rheumatoid Arthritis
International Journal of Inflammation
Allergy
Immunology
Pms47 - Cost-Effectiveness of Tofacitinib Compared With Adalimumab in the Treatment of Moderate to Severe Rheumatoid Arthritis in Iran
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness Analysis of Baricitinib Versus Adalimumab for the Treatment of Moderate-To-Severe Rheumatoid Arthritis in Spain
ClinicoEconomics and Outcomes Research
Health Policy
Economics
Econometrics
Finance
PMS13 Cost-Effectiveness of Biological Treatments in Patients With Rheumatoid Arthritis in Taiwan
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pms41 - Cost-Effectiveness Analysis of Tofacitinib in Combination With Methotrexate in the Treatment of Moderate to Severe Rheumatoid Arthritis in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
PMS30 Cost-Effectiveness of Tocilizumab Compared to Standard Therapeutic Sequences for the Treatment of Moderate/Severe Rheumatoid Arthritis (RA) Patients in Portugal
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Tofacitinib: A Janus Kinase Inhibitor for Rheumatoid Arthritis
Prescriber
Pharmacology
